All Type of News
Increasing number of pharmaceutical products being stored in factory storage
Due to the slump in exports and domestic sales, the Korean economy has been on red alert as having products stocked in factories’ storage; how about the pharmaceutical industry?
Although the pharmaceutical industry i...
What are trends and strategies of KRW 400 billion pharmaceutical/medical advertisement market?
The 2015’s pharmaceutical and medical advertisement market was ranked on the 6th in the entire industry group based on the amount of investments. The cosmetic and health product advertisement market was positioned at ...
Life Prolongation Decision Act will decrease anticancer market?
If the ‘Act on the Decision for Life Prolongation for Patients on Hospice, Palliative Care and Dying(Life Prolongation Decision Act)’ officially announced last February is enforced, will anticancer prescriptions decre...
“It is an unfair action to exclude blood vessel laser treatment from health insurance”
The medical field has made strong opposition to the exemption of the blood vessel laser treatment, one of varicose vein surgeries, from the health insurance.
From January of the year, the Financial Supervisory Servi...
Generics poured out before ‘ezetimibe’ patent expiration of KRW 60 billion
Facing the patent expiration of the ezetimibe drug(product name: Ezetrol), a hyperlipidemia treatment, a number of ezetimibe+statin complexes emerged and foretold fierce competition.
The substance patent expiration o...
Over NIP, MSD and GSK requests for double and single prices respectively
While negotiations for cervical cancer vaccines have started among the Korea Center for Disease Control and Prevention(KCDC), MSD and GSK, the two companies were observed to hope double price and single price respecti...
Listed pharmaceutical companies decides largest cash dividends ever, KRW 250 billion
Listed pharmaceutical companies’ cash dividends were confirmed to reach KRW 250 billion this year. Moreover, 5 pharmaceutical companies including Hanmi Science were observed to reach KRW 20 billion cash dividends.
Ac...
Blue House interviewed 5 companies last year, “We will take care of pharmaceutical industry”
Difficulties pharmaceutical companies experienced in the process of foreign expansion have been directly taken care of by the Blue House.
According to the industry concerned on the 7th, the Blue House listened to di...
KRW 100 billion Viread market preoccupied by Chong Kun Dang
Chong Kun Dang has took a step forward for commercialization of an incrementally modified drug of Viread(generic name: tenofovir), a chronic hepatitis B treatment.
The Ministry of Food and Drug Safety(MFDS) approved...
Novartis loses against Dongkook Pharmaceutical over hyperpituitarism patent
Novartis lost on a trail for injunction against infringement of the hyperpituitarism patent against Dongkook Pharmaceutical.
The 11th Civil Affairs Division, Seoul Central District Court, dismissed the request for in...
